In this episode of the n-Lorem Patient Empowerment Program Podcast, Dr. Stan Crooke is joined by n-Lorem patient Bill O’Sullivan and Dr. Neil Shneider to discuss Bill’s experience living with a rare inherited form of ALS caused by a CHCHD10 mutation. Bill shares his path to diagnosis, the impact of genetic testing, and his experience receiving a personalized antisense oligonucleotide (ASO) treatment designed to target the underlying cause of his disease. Together, they discuss how advances in genetics and precision medicine are creating new possibilities for patients and families affected by rare neurodegenerative diseases.

On this episode we discuss:

  • 00:00 Introduction
  • 00:58 Meet Bill O’Sullivan and Dr. Neil Shneider
  • 03:17 Family history and inherited ALS
  • 06:37 Diagnosis and discovery of CHCHD10
  • 10:02 Early symptoms and diagnostic challenges
  • 20:20 Beginning personalized ASO treatment
  • 22:33 Treatment results and disease stabilization
  • 23:42 Looking ahead: earlier intervention and future generations
  • 27:57 Expanding treatment opportunities through genetic research

Links:

This episode is made possible thanks to our sponsor ChemGenes

Donate to n-Lorem and Make Hope Possible

Register to attend the 2026 Nano-rare Patient Colloquium

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör n-Lorem Foundation (Dr. Stan Crooke, Amy Williford, Kim Butler, Andrew Serrano, Jon Magnuson, and Kira Dineen). Innehållet i podden är skapat av n-Lorem Foundation (Dr. Stan Crooke, Amy Williford, Kim Butler, Andrew Serrano, Jon Magnuson, and Kira Dineen) och inte av, eller tillsammans med, Poddtoppen.